AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials
Thrombosis Research · 2024
DOI: 10.1016/j.thromres.2020.12.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis Research, 2024. Verfasst von Vincent Muczynski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University College London - Cancer Institute, United Kingdom of Great Britain and Northern Ireland. Hauptthemen laut MEDLINE: Hemophilia B. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, University College London - Cancer Institute, United Kingdom of Great Britain and Northern Ireland.
- Department of Haematology, University College London - Cancer Institute, United Kingdom of Great Britain and Northern Ireland; Katharine Dormandy Haemophilia and Thrombosis Unit, Royal Free London NHS Foundation Trust,…
Zitieren
APA
Muczynski, V., & Nathwani, A. C. (2024). AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials. Thrombosis Research. https://doi.org/10.1016/j.thromres.2020.12.033
Vancouver
Muczynski V, Nathwani AC. AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials. Thrombosis Research. 2024. doi:10.1016/j.thromres.2020.12.033
BibTeX
@article{Muczynski2024,
author = {Muczynski, Vincent and Nathwani, Amit C},
title = {AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials},
journal = {Thrombosis Research},
year = {2024},
doi = {10.1016/j.thromres.2020.12.033}
}
EUVIMED